SCHEMBL10577333

SCHEMBL10577333

ICCCCc1c[nH]c2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.61
HTR2A P28223 4/20 0.61
CYP3A4 P08684 2/20 0.61
HTR2C P28335 2/20 0.61
HTR6 P50406 2/20 0.61
MPO P05164 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2A6 P11509 1/20 0.61
NFKB1 P19838 1/20 0.61
HTR1D P28221 1/20 0.61
HTR1B P28222 1/20 0.61
HTR7 P34969 1/20 0.61
CTSK P43235 1/20 0.61
CYP2A13 Q16696 1/20 0.61
TAAR1 Q96RJ0 1/20 0.61
HTR1A P08908 4/20 0.59
PMP22 Q01453 1/20 0.59
MAPT P10636 2/20 0.58
TDP1 Q9NUW8 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL318663 0.95 SLC6A4 (0.63) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL7004146 0.91 HTR2A (0.71) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL7889427 0.89 HTR2A (0.69) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL7004071 0.89 HTR2A (0.69) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL7001306 0.89 HTR2A (0.69) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL4229484 0.87 HTR2A (0.67) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL29756457 0.87 HTR2A (0.67) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL7005718 0.87 HTR2A (0.71) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL4985934 0.82 HTR2A (0.77) SLC6A4HTR2ACYP3A4HTR2CHTR6
SCHEMBL4636791 0.82 SLC6A4 (0.61) SLC6A4HTR2ACYP3A4HTR2CHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180193330-A1 ALKYLATED TETRAHYDROISOQUINOLINES FOR BINDING TO CENTRAL NERVOUS SYSTEM RECEPTORS FLORIDA A&M UNIVERSITY 2018-07-12 US disclosed
US-4870087-A Indole containing, 2-thienyl-1,2,3,6-tetrahydropyridyls and their pharmaceutical use MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-09-26 US disclosed
US-4251538-A Indolealkylamines and processes for their preparation MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1981-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180193330-A1 ALKYLATED TETRAHYDROISOQUINOLINES FOR BINDING TO CENTRAL NERVOUS SYSTEM RECEPTORS NTSR2, HTR3B, NTSR1 SLC6A4 101/4885HTR2A 13/4885CYP3A4 1267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.